New Risk • May 29
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩143.1b (US$94.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Share price has been highly volatile over the past 3 months (19% average weekly change). Revenue has declined by 9.0% over the past year. Minor Risks Less than 3 years of financial data is available. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.4% net profit margin). Market cap is less than US$100m (₩143.1b market cap, or US$94.9m). New Risk • Apr 09
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩146.6b (US$99.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Share price has been highly volatile over the past 3 months (20% average weekly change). Revenue has declined by 9.0% over the past year. Minor Risks Less than 3 years of financial data is available. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.4% net profit margin). Market cap is less than US$100m (₩146.6b market cap, or US$99.0m). 공고 • Feb 24
Amosense Co.,Ltd., Annual General Meeting, Mar 24, 2026 Amosense Co.,Ltd., Annual General Meeting, Mar 24, 2026, at 11:00 Tokyo Standard Time. Location: conference room, 90, 4sandan 5-gil, jiksan-eup, seobuk-gu, chungcheongnam-do, cheonan South Korea New Risk • Feb 11
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Share price has been volatile over the past 3 months (10% average weekly change). New Risk • Aug 29
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risk Market cap is less than US$100m (₩98.6b market cap, or US$70.9m). New Risk • Aug 13
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩78.3b market cap, or US$56.6m). Valuation Update With 7 Day Price Move • Jun 02
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to ₩7,380, the stock trades at a trailing P/E ratio of 47.6x. Average trailing P/E is 14x in the Electronic industry in South Korea. Total loss to shareholders of 58% over the past three years. New Risk • Feb 21
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -₩19b This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩19b free cash flow). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩70.4b market cap, or US$49.1m). 공고 • Feb 21
Amosense Co.,Ltd., Annual General Meeting, Mar 24, 2025 Amosense Co.,Ltd., Annual General Meeting, Mar 24, 2025, at 11:30 Tokyo Standard Time. Location: conference room, 20-3, 4sandan 2-gil, jiksan-eup, seobuk-gu, chungcheongnam-do, cheonan South Korea Buy Or Sell Opportunity • Feb 11
Now 21% undervalued Over the last 90 days, the stock has risen 1.4% to ₩6,340. The fair value is estimated to be ₩8,008, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 30% over the last 3 years. Earnings per share has grown by 57%. New Risk • Feb 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Less than 1 year of cash runway based on current free cash flow (-₩19b). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩75.1b market cap, or US$51.9m). Breakeven Date Change • Dec 31
Forecast breakeven date pushed back to 2025 The analyst covering AmosenseLtd previously expected the company to break even in 2024. New forecast suggests the company will make a profit of ₩10.5b in 2025. Average annual earnings growth of 74% is required to achieve expected profit on schedule. New Risk • Dec 16
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩62.8b market cap, or US$43.7m). Buy Or Sell Opportunity • Nov 27
Now 23% undervalued after recent price drop Over the last 90 days, the stock has fallen 22% to ₩6,130. The fair value is estimated to be ₩7,976, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 78%. Buy Or Sell Opportunity • Nov 12
Now 22% undervalued after recent price drop Over the last 90 days, the stock has fallen 22% to ₩6,320. The fair value is estimated to be ₩8,120, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Earnings per share has grown by 78%. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₩7,510, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 11x in the Electronic industry in South Korea. Total loss to shareholders of 56% over the past three years. New Risk • Jun 08
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 1.7x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). High level of non-cash earnings (44% accrual ratio). Minor Risk Market cap is less than US$100m (₩130.9b market cap, or US$94.9m). 공고 • Apr 27
Amosense Co.,Ltd. announced that it has received KRW 10 billion in funding from KB Investment Co., Ltd, Mirae Asset Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., EBEST Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd. On April 26, 2024, Amosense Co.,Ltd. closed the transaction. 공고 • Apr 24
Amosense Co.,Ltd. announced that it expects to receive KRW 10 billion in funding from KB Investment Co., Ltd, Mirae Asset Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., EBEST Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd. Amosense Co.,Ltd announced a private placement of Series 2 Bearer-bearing interest-bearing, unsecured private placement convertible bonds for gross proceeds of KRW 10,000,000,000 on April 24, 2024. The transaction includes participation from Mirae Asset Securities Co., Ltd, Shinhan Investment & Securities Co., Ltd., EBEST INVESTMENT & SECURITIES Co., Ltd, KB Securities Co., Ltd., NH Investment & Securities Co., Ltd. and Samsung Securities Co., Ltd. The Notes bear interest rate of zero percent and matures on April 26, 2029. The notes are convertible into 868,281 shares with a conversion price of KRW 11,517 per share representing conversion rate of 7.18%. Conversion claim period is April 26, 2025 to March 26, 2029. The transaction has been approved by the board of directors of the company. The transaction is expected to close on April 26, 2024. Breakeven Date Change • Dec 31
Forecast breakeven date pushed back to 2024 The analyst covering AmosenseLtd previously expected the company to break even in 2023. New forecast suggests the company will make a profit of ₩6.20b in 2024. Average annual earnings growth of 94% is required to achieve expected profit on schedule. Breakeven Date Change • Nov 30 The analyst covering AmosenseLtd previously expected the company to break even in 2023. New forecast suggests the company will make a profit of ₩2.20b in 2023. Earnings growth of 1.9% is required to achieve expected profit on schedule.
Breakeven Date Change • Nov 23
Forecast to breakeven in 2023 The analyst covering AmosenseLtd expects the company to break even for the first time. New forecast suggests the company will make a profit of ₩2.90b in 2023. Earnings growth of 77% is required to achieve expected profit on schedule. New Risk • Oct 10
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩132.4b (US$98.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (16% average weekly change). Minor Risk Market cap is less than US$100m (₩132.4b market cap, or US$98.3m). New Risk • Aug 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Breakeven Date Change • Nov 16
Forecast breakeven date pushed back to 2023 The analyst covering AmosenseLtd previously expected the company to break even in 2022. New forecast suggests losses will reduce by 100% to 2022. The company is expected to make a profit of ₩4.10b in 2023. Average annual earnings growth of 118% is required to achieve expected profit on schedule. Breakeven Date Change • Apr 27
Forecast to breakeven in 2022 The analyst covering AmosenseLtd expects the company to break even for the first time. New forecast suggests the company will make a profit of ₩6.90b in 2022. Earnings growth of 116% is required to achieve expected profit on schedule. 
